APHIOS CORPORATION

Company Information
Address 3 E GILL ST
WOBURN, MA, 01801-1720


Information

DUNS: 194643722

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. CFI Pathogen Inactivation of Human Plasma Units

    Amount: $1,558,277.00

    PROJECT SUMMARY The rapid spread of the Zika viruswhich can have a significant impact on neurological disorders in unborn fetuses and potentially adultsthe recent outbreak of the extremely virulent Eb ...

    SBIRPhase II2019Department of Health and Human Services National Institutes of Health
  2. CFI Pathogen Inactivation of Human Plasma Units

    Amount: $599,617.00

    PROJECT SUMMARY The rapid spread of the Zika viruswhich can have a significant impact on neurological disorders in unborn fetuses and potentially adultsthe recent outbreak of the extremely virulent Eb ...

    SBIRPhase I2018Department of Health and Human Services
  3. CRITICAL FLUID NANOSOMES FOR EFFECTIVE TARGETED DELIVERY AND MANUFACTURE OF SIRNA BASED THERAPEUTICS

    Amount: $299,591.00

    RNA based vaccines and therapeutics have emerged as great promise for HIV prevention and treatment respectively However many obstacles still need to be overcome in particular RNA instability manu ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  4. Purging Latent HIV Reservoirs through a Combination HIV Therapeutic

    Amount: $1,088,559.00

    PROJECT SUMMARY We hypothesize that Protein Kinase C PKC agonists such as the non tumorigenic Bryoids combined with HDAC inhibitors HDACi represent a valuable pharmacological approach to purge lat ...

    SBIRPhase I2016Department of Health and Human Services
  5. Development of cGMP Manufacturing Process for CBD

    Amount: $1,484,298.00

    DESCRIPTION provided by applicant Medical marijuana is now approved in states and the District of Columbia for several medical conditions such as cachexia cancer chronic pain epilepsy and oth ...

    SBIRPhase II2015Department of Health and Human Services
  6. Development of SFS Fractionators

    Amount: $224,947.00

    DESCRIPTION (provided by applicant): The screening of a complex mixture of analytes is not always successful in sensitive screens for specific activities. Often, specific activities are masked by inte ...

    SBIRPhase I2014Department of Health and Human Services
  7. Development of cGMP Manufacturing Process for CBD

    Amount: $224,841.00

    DESCRIPTION (provided by applicant): Medical marijuana is now approved in 20 states and the District of Columbia for several medical conditions such as cachexia, cancer, chronic pain, epilepsy and oth ...

    SBIRPhase I2014Department of Health and Human Services
  8. Alzheimer's Disease Therapeutic

    Amount: $2,409,606.00

    DESCRIPTION (provided by applicant): Alzheimer's Disease (AD) is a significant neurological disorder that afflicts more than 4.5 million Americans and more than 10 million people worldwide. The l ...

    SBIRPhase II2011Department of Health and Human Services
  9. TAS:: 75 0896::TAS SBIR PHASE I TOPIC NCCAM 002

    Amount: $94,448.00

    This Phase I, SBIR contract is to conduct a thorough biological and phytochemical analysis of Harpagophytum procumbens. This should result in discovery of new biologically active molecules and/or a mo ...

    SBIRPhase I2011Department of Health and Human Services
  10. SBIR PHASE 1 TOPIC 43

    Amount: $149,440.00

    The contractor will identify methodologies for broad spectrum inactivation of pathogens in red blood cell concentrates(RBCC). RBCCs are the main components of blood used in transfusion medicine, yet c ...

    SBIRPhase I2011Department of Health and Human Services
US Flag An Official Website of the United States Government